Rapid Nutrition PLC (RPNRF) Fair Value & Analysis
Consumer Defensive · US · Market cap $4.7M
Rapid Nutrition PLC
RPNRF · US
Fair value as of: Jun 26, 2026
From 1 valuation models · updated 16 days ago
Fair value updated Jun 26, 2026 — revised from $0.0600 to $0.0110 (−81.7%) since Jun 24, 2026.
Price vs Fair Value (12 months)
12‑month range $0.0100 – $10,000 · fair‑value band $0.0100 – $0.0110 · the $0.0100 price screens below the $0.0110 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Rapid Nutrition PLC (RPNRF) currently trades at $0.0100, while our model-based Fair Value estimate is $0.0110 — implying the stock looks roughly 10.0% undervalued today. We read business quality at 31/100 (below-average quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Trailing-twelve-month revenue stands at $754K. Revenue declined 59.0% year over year. Fundamentals as of Jun 26, 2026
Our scenario range runs from $0.0100 (bear case) to $0.0110 (bull case); at $0.0100, the current price sits within that range. For context, the median of 10 Consumer Defensive peers we cover trades at -21% fair-value upside — at 10%, RPNRF screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
Rapid Nutrition PLC, a natural healthcare company, develops and distributes science-based health and wellness products worldwide. The company offers natural and organic ingredients designed for weight loss under the System LS brand; herbal medicine for symptoms of sore throat, colds, and flu, as well as added Ashwagandha and Andrographis for strong immunity boost for travelers under the Azurene brand. It also provides products under the third-party brands. Rapid Nutrition PLC was founded in 2001 and is based in Mildenhall, the United Kingdom.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Rapid Nutrition PLC reported revenue of $194K in FY2025 versus $3.0M in FY2021, a compound −49.6%/yr. Reported net income was −$3.1M in FY2025.
Is RPNRF fairly valued? → Check now
Similar stocks
10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé S.A NSRGF | $98.16 | $70.25 | -28% |
| Nestlé India Limited NESTLEIND | ₹1,402 | ₹362.37 | -74% |
| Grupo Bimbo, S.A. BIMBOA | 57.10 MXN | 45.03 MXN | -21% |
| Uni-President Enterprises Corp 1216 | 73.80 TWD | 61.57 TWD | -17% |
| Britannia Industries Limited BRITANNIA | ₹5,121 | ₹1,374 | -73% |
| Tata Consumer Products Limited TATACONSUM | ₹1,131 | ₹339.05 | -70% |
| PT Indofood CBP Sukses Makmur Tbk ICBP | 6,600 IDR | 14,500 IDR | +120% |
| Samyang Foods Co 003230 | 1,139,000 KRW | 1,010,543 KRW | -11% |
| PT Indofood Sukses Makmur Tbk INDF | 6,725 IDR | 25,554 IDR | +280% |
| Patanjali Foods Limited PATANJALI | ₹420.45 | ₹294.68 | -30% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Rapid Nutrition PLC (RPNRF) undervalued?
What is the fair value of RPNRF?
What is the quality score of RPNRF?
What is the revenue of Rapid Nutrition PLC (RPNRF)?
What is the net profit margin of RPNRF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Unlock the full Rapid Nutrition PLC analysis — and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.